Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold—if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Predictive Oncology Inc. (POAI) Reports Q1 Loss of $0.93
June 8, 2020 4:23 PM EDTPredictive Oncology Inc. (NASDAQ: POAI) reported Q1 EPS of ($0.93), versus ($2.09) reported last year. Revenue for the quarter came in at $295.94 thousand, versus $255.24 thousand reported last year.
We remain steadfast in our approach to assembling a portfolio of assets that leverages our unique collection of cancer tumors to develop and market AI-based, predictive models for personalized cancer treatments that improve patient outcomes, commented Dr. Carl Schwartz, Predictive Oncology CEO. Our collection of more than 150,000 cancer tumors, amassed and... More
